About this trial
Sarcopenia can be easily observed in patients with hemodialysis. However, there were few studies on the precise concept and diagnostic criteria for sarcopenia in patients with hemodialysis. The investigators have already recognized the sarcopenia-associated mortality and morbidity in patients with hemodialysis. However, intervention studies on hemodialysis patients with sarcopenia have not been conducted until now. In 2021, the investigators conducted a pilot study to evaluate the effectiveness of the combined exercise and nutrition intervention for sarcopenia in patients with hemodialysis to confirm the effectiveness. This study is a follow-up study, conducted as a randomized controlled trial.
Eligibility criteria
Qualifiers
Patients with hemodialysis
Community-dwellers
Able to walk with or without assistive devices for more than 100 meters
Disqualifiers
A person with cancer disease.
People with psychiatric symptoms.
A person who has an absorption disorder or has a history of resection of the small intestine or colon
Pregnant women
Trial design
Treatments tested in this trial
- exercise and nutritional support